跳至主要内容
临床试验/CTRI/2019/06/019538
CTRI/2019/06/019538尚未招募2 期

Therapeutic evaluation of Safoof-e-Patthar phori with Sharbat bazoori moatadil in patients of Hasat-ul-Kulya (Renal Stone).An Observational Clinical Study

ational Institute of Unani Medicine0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1 Diagnosed case of Hasat-ul-Kulya(Renal stone) upto 10mm (radiological evidence of stone up to 10mm).
  • 2 Patients of age group between 18-65 years.
  • 3 Patients of both sexes.
  • 4 Patients who have agreed to sign the informed consent form and follow up the protocol.

排除标准

  • 1 Stone size more than 10mm.
  • 2 K/C/O Diabetes mellitus.
  • 3 Pregnant and lactating women.
  • 4 Gross hydronephrosis
  • 5 Raised Blood urea or serum creatinine
  • 6 Bladder outlet obstruction
  • 7 Serious systemic illness

研究者

发起方
ational Institute of Unani Medicine

相似试验

Study of Unani drugs in Kidney Stone | 临床试验